Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AR | P10275 | 6/20 | 0.49 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.36 |
| ▸ | KIF11 | P52732 | 1/20 | 0.36 |
| ▸ | PGR | P06401 | 2/20 | 0.36 |
| ▸ | XDH | P47989 | 2/20 | 0.34 |
| ▸ | ALOX5AP | P20292 | 1/20 | 0.34 |
| ▸ | FEN1 | P39748 | 1/20 | 0.34 |
| ▸ | S1PR1 | P21453 | 2/20 | 0.33 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.33 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.33 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.33 |
| ▸ | SCN9A | Q15858 | 2/20 | 0.33 |
| ▸ | BCAT1 | P54687 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20111821 | 0.97 | AR (0.52) | ARTRPA1KIF11PGRXDH | |
| SCHEMBL20111820 | 0.94 | AR (0.49) | ARTRPA1KIF11PGRXDH | |
| SCHEMBL21258755 | 0.94 | AR (0.49) | ARTRPA1KIF11PGRXDH | |
| SCHEMBL25660835 | 0.94 | AR (0.47) | ARTRPA1KIF11PGRXDH | |
| SCHEMBL21258882 | 0.93 | AR (0.41) | ARTRPA1KIF11PGRXDH | |
| SCHEMBL20111839 | 0.93 | AR (0.51) | ARTRPA1KIF11PGRXDH | |
| SCHEMBL20111614 | 0.93 | AR (0.41) | ARTRPA1KIF11PGRXDH | |
| SCHEMBL21258845 | 0.92 | AR (0.39) | ARTRPA1KIF11PGRXDH | |
| SCHEMBL21258758 | 0.92 | AR (0.52) | ARTRPA1PGRXDHALOX5AP | |
| SCHEMBL25659474 | 0.91 | AR (0.49) | ARTRPA1PGRS1PR1PDE3B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10971688-B2 | Organic molecules for use in organic optoelectronic devices | CYNORA GMBH (DE) | 2021-04-06 | — | — | US | disclosed |
| US-20190248741-A1 | ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2019-08-15 | — | — | US | disclosed |
| WO-2018077492-A1 | ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | CYNORA GMBH (DE) | 2018-05-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10971688-B2 | Organic molecules for use in organic optoelectronic devices | OR10J3, OR51E2, OPRM1 | AR 4611/4885TRPA1 39/4885KIF11 3426/4885 |
| US-20190248741-A1 | ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | OR10J3, ORC3, AOC3 | AR 4386/4885TRPA1 657/4885KIF11 3661/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.